Blog: Don’t suspend IP protections on Covid-19 diagnostics and therapeutics, 10/31/2022
Blog: Don’t suspend IP protections on Covid-19 diagnostics and therapeutics, 10/31/2022 Read More »
Bipartisan Advocacy Coalition From Former Obama and Trump Officials Launches Major Advertising Campaign
WASHINGTON (October 26, 2022) — This week, the Council for Innovation Promotion, a bipartisan coalition dedicated to promoting strong and effective intellectual property rights, launched its first major advertising campaign to highlight the important role Members of Congress play in ensuring the United States maintains its leadership in the innovation economy. C4IP’s digital advertisements will
Letters Seek to Dispel Gene Patent ‘Scaremongering’ Surrounding Tillis’ Patent Eligibility Bill
“Any suggestion that this legislation would allow companies to patent anyone’s DNA is simply false,” C4IP writes, adding that the ‘scaremongering’…ignores the fact that the human genome has already been published many times over and is already available for scientific use.”
Scapegoating Patents Won’t Lower Drug Prices
In their quest to lower drug prices, some US leaders have identified a convenient scapegoat: patents.
Scapegoating Patents Won’t Lower Drug Prices Read More »
Patents for Human Genes, Diagnostic Tests Generate Policy Debate
Isolated human genes would be patentable, and the costs of medical diagnostic tests would jump under a recently introduced bill to revamp patent eligibility, panelists at an American Civil Liberties Union virtual briefing said Monday—a stance that former patent officials labeled “scaremongering.”
Patents for Human Genes, Diagnostic Tests Generate Policy Debate Read More »
Intellectual property rights are the heroes of America’s innovation story
It’s no secret that the film industry looks different than it did when I worked in Hollywood decades ago. Gone are the days when eager movie-goers’ only option was to pile into theaters to watch the latest hit. Today, many Americans can enjoy watching films from the comfort of their own homes. The way we
Intellectual property rights are the heroes of America’s innovation story Read More »
New high-level lobby group will promote role of IP in US innovation
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
New high-level lobby group will promote role of IP in US innovation Read More »
Senator Coons’ co-sponsorship of Tillis bill potential breakthrough for patent eligibility
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Bipartisan Group Aims To Halt ‘Downward’ Slide Of IP System
Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.
Bipartisan Group Aims To Halt ‘Downward’ Slide Of IP System Read More »
Celebrating the Launch of the Council for Innovation Promotion
On Wednesday, September 28, more than 100 friends of the Council for Innovation Promotion gathered to celebrate its launch. Distinguished guests included Sen. Chris Coons (D-DE), Sen. Thom Tillis (R-NC), and Rep. Thomas Massie (R-KY). Our honored guests offered remarks at the event along with C4IP’s co-chairs, Andrei Iancu and David Kappos, and C4IP’s two
Celebrating the Launch of the Council for Innovation Promotion Read More »